Drug Topics

SEPTEMBER 7, 2022

Even “THC-free” cannabidiol products may contain trace amounts of THC.

244

244

Pharmacy Times

SEPTEMBER 9, 2022

Prescription drug monitoring programs have decreased prescription opioids in the United States but resulted in unintended spikes of illegal drug use and heroin-related deaths.

172

172

STAT

SEPTEMBER 8, 2022

At the end of an unusual and dramatic meeting on Wednesday, an independent panel of advisers to the Food and Drug Administration recommended the approval of a new drug to treat people with ALS developed by Amylyx Pharmaceuticals. The vote was 7-2, a substantial margin of support for the Amylyx drug called AMX0035 and a reversal of the same group’s vote against the drug last March.

FDA 145

FDA 145

pharmaphorum

SEPTEMBER 5, 2022

Sam Crowther, founder and CEO of cybersecurity company Kasada, tells us about a recent discovery his company made that revealed tens of thousands of accounts with prescription drug attachments in major online pharmacies had been compromised. While performing analysis for a client of online accounts for sale, Kasada uncovered a new and illegal way bots are being used – to steal pharmacy customers’ accounts and resell prescriptions on a secondary market for in-demand substances, such as Oxyc

Compounding 138

Compounding Controlled Substances 138

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

SEPTEMBER 9, 2022

Are prescription cap laws for opioids effective for children and teenagers?

231

231

Pharmacy Times

SEPTEMBER 6, 2022

Cognitive harm appears reversible, results of analysis by Nemours Children’s Health Jacksonville and Stanford University shows.

149

149

PharmaVoice

SEPTEMBER 6, 2022

From standout executives to R&D pioneers — this year’s class of honorees is defining the next era of leadership.

137

137

Drug Topics

SEPTEMBER 7, 2022

When it comes to the COVID-19 vaccine, independent pharmacies are being set up to fail by federal health partners.

Independent Pharmacies 227

Independent Pharmacies Vaccines 227

Pharmacy Times

SEPTEMBER 6, 2022

Analysis shows that over 5 years, the percentage of women without relapse was 89% for those who had hormonal stimulation of the ovaries and 83% for those with ovarian tissue freezing.

139

139

STAT

SEPTEMBER 8, 2022

Gilead Sciences said Wednesday that its cancer drug Trodelvy prolonged the survival of women with the most common form of breast cancer by just under 30% — a clinical trial result that could lead to a better treatment option for patients with advanced disease and strengthen the drug’s commercial outlook. In the study, called TROPICS-02, Trodelvy showed a median overall survival of 14.4 months compared to 11.2 months for comparator chemotherapy.

Chemotherapy 141

Chemotherapy 141

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

SEPTEMBER 8, 2022

Tetra Bio-Pharma and Cellvera have entered an agreement to jointly develop ARDS-003 as an oral combination therapeutic candidate with 400mg Qifenda (Favipiravir) for Covid-19. A first-in-human drug product, ARDS-003 contains the active pharmaceutical agent, Onternabez. Onternabez is a selective full agonist of the type 2 cannabinoid receptor (CB2R).

Pharmaceutical Companies 132

Pharmaceutical Companies Pharmaceutical Companies Immunization 132

Drug Topics

SEPTEMBER 7, 2022

CBD products range from gummies to tinctures to topical lotions and creams.

212

212

Pharmacy Times

SEPTEMBER 8, 2022

Patients should discuss efficacy and potential drug interactions with clinicians before use, study authors indicate.

132

132

STAT

SEPTEMBER 8, 2022

Nothing has made the nation’s addiction epidemic more deadly than fentanyl’s infiltration of the drug supply. Yet in more than a dozen states, tools used to detect the ultra-potent synthetic opioid are still classified as drug paraphernalia — making it a crime to possess or distribute them. The practice of “drug-checking” — essentially, testing illicit drugs to see if they contain unknown toxins — has remained controversial even as the crisis of f

140

140

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PhRMA

SEPTEMBER 9, 2022

America leads the world in biomedical innovation today because our system rewards investment in research and discovery of new treatments. Now, with the passage of the Inflation Reduction Act , Dr. Steven Pearson, president of the Institute for Clinical and Economic Review (ICER), coolly admits we will see fewer new cures and treatments and suggests that trade-off is one we need to make.

130

130

Drug Topics

SEPTEMBER 8, 2022

Addressing patient concerns about cannabidiol can be the key to patient satisfaction.

211

211

Pharmacy Times

SEPTEMBER 8, 2022

Pharmacists handle public vaccination efforts and need to assess where patients are on the hesitancy spectrum to provide reliable information.

Vaccines 132

Vaccines 132

STAT

SEPTEMBER 8, 2022

A daily dose of Relay Therapeutics’ experimental drug for cholangiocarcinoma, a rare cancer of the bile ducts, led to tumor shrinkage of a third or more in 15 of 17 patients with metastatic disease, the company said Wednesday. The results were released in an abstract at the annual meeting of the European Society of Molecular Oncology, where they will be presented in full on Sunday.

140

140

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

SEPTEMBER 7, 2022

Brainomix has reeled in another pharma partner for its artificial intelligence-powered biomarker software, used to track the performance of therapeutic interventions in clinical trials. South Korea’s Bridge Biotherapeutics has signed up to use the UK medtech firm’s e-ILD software package in a phase 2 trial of BBT-877, its experimental therapy for serious lung disease idiopathic pulmonary fibrosis (IPF).

Packaging 128

Packaging 128

Drug Topics

SEPTEMBER 9, 2022

Software updates in closed-loop systems may lead to better time in range numbers for children with type 1 diabetes.

207

207

Pharmacy Times

SEPTEMBER 8, 2022

Dr. Tom Lodise provides an overview of gut microbiota and the consequences of dysbiosis.

132

132

STAT

SEPTEMBER 5, 2022

By this time next year, if the medical forecasts are correct, I will probably be dead, another casualty of a fatal illness that most people have never heard of: idiopathic pulmonary fibrosis (IPF). This condition has been described by Michael J. Stephen in his 2021 book “Breath Taking” as the “most frustrating and disheartening of all the diseases in pulmonary medicine.

139

139

Drug Store News

SEPTEMBER 7, 2022

Lannett anticipates launching biosimilar insulin glargine in the first half of 2024.

127

127

Drug Topics

SEPTEMBER 9, 2022

Address vaccine hesitancy at your pharmacy to encourage patients and their families to get vaccinated against COVID-19, flu, and more.

Vaccines 201

Vaccines 201

Pharmacy Times

SEPTEMBER 7, 2022

One-third of participants who have used prescriptions think that mail-order pharmacies would help reduce drug costs, according to HealthCare.com.

Mail-Order Pharmacies 132

Mail-Order Pharmacies 132

STAT

SEPTEMBER 7, 2022

For Illumina, the leading maker of DNA sequencing equipment, there was bad news and worse news Tuesday. The bad news: The European Commission said it was blocking Illumina’s $8 billion acquisition of Grail, a firm focused on the early detection of cancer. The worse news? In its press release on the ruling, Illumina acknowledged that, although it will appeal, that may not prevent the European Commission from forcing it to divest Grail, which it purchased before regulatory approvals were in

133

133

European Pharmaceutical Review

SEPTEMBER 7, 2022

The second most commonly used pharmaceutical dosage form, capsules, are anticipated to be a $5.2 billion market by 2030, growing from a 2020 value of around $2.4 billion. 1 Here experts Torkel Gren of Recipharm and Dr Jnanadeva Bhat of ACG-Worldwide share key developments in capsules by answering four key questions. What are the major trends in capsule development?

Dosage 124

Dosage Vaccines 124

Drug Topics

SEPTEMBER 8, 2022

Encouraging outcomes in recent studies have researchers calling for more analysis of the effect of cannabinoids on sleep disorders.

201

201

Pharmacy Times

SEPTEMBER 6, 2022

Patients with chronic migraines and higher frequencies of pain experienced the lowest vitamin B12 levels compared with patients with less frequent or no headache symptoms.

132

132

STAT

SEPTEMBER 9, 2022

“I really believe this is why God gave us two arms — one for the flu shot and the other one for the Covid shot.” — Ashish Jha, White House Covid coordinator, Sept. 6, 2022. As the promotional push to get people vaccinated with one of the updated, bivalent Covid vaccines heats up, federal health authorities are urging Americans to consider getting their Covid shot and their flu shot at the same time.

Vaccines 131

Vaccines 131

PharmaVoice

SEPTEMBER 6, 2022

With his unique platform, the has built a bridge between patients, physicians and researchers around the world.

116

116

Drug Topics

SEPTEMBER 7, 2022

Keep your pharmacy vaccine-ready for your youngest patients with the most current influenza vaccination information from the American Academy of Pediatrics.

Vaccines 201

Vaccines 201

Pharmacy Times

SEPTEMBER 8, 2022

Pharmacy managers should have recommendations for how staff pharmacists and even technicians will improve the education and mentoring of future pharmacists.

131

131